A Sign of the Times: Chi-Med’s MediPharma Steps Toward Independence
This article was originally published in PharmAsia News
Executive Summary
Accompanying the solid interim results announced by Hutchison China MediTech this week was an interesting indication of both the success of Chi-Med's Hutchison MediPharma R&D subsidiary and the evolution of the nascent biotech industry in China